References
- Raj A, Gupta B, Chowdhury A, Chadha S. A study of voice changes in various phases of menstrual cycle and in postmenopausal women. J Voice 2010;24:363–8.
- Abitbol J, Abitbol P, Abitbol B. Sex hormones and the female voice. J Voice 1999;13:424–46
- Voelter C, Kleinsasser N, Joa P, et al. Detection of hormone receptors in the human vocal fold. Eur Arch Oto-Rhino-Laryngol 2008;265:1239–44
- Mendes-Laureano J, Sá MFS, Ferriani RA, et al. Comparison of fundamental voice frequency between menopausal women and women at menacme. Maturitas 2006;55:195–9
- D’haeseleer E, Depypere H, Claeys S, Wuyts FL, De Ley S, Van Lierde KM. The impact of menopause on vocal quality. Menopause 2011;18:267–72
- Nordenskjöld F, Fex S. Vocal effects of danazol therapy: a preliminary report. Acta Obstet Gynecol Scand 1984;63:131–2
- Pattie MA, Murdoch BE, Theodoros D. Voice changes following androgenic hormone treatment in women. Asia Pacific J Speech Lang Hear 2001;6:77–83
- Pattie MA, Murdoch BE, Theodoros D, Forbes K. Voice changes in women treated for endometriosis and related conditions: the need for comprehensive vocal assessment. J Voice 1998;12:366–71
- Damrose EJ. Quantifying the impact of androgen therapy on the female larynx. Auris Nasus Larynx 2009;36:110–12
- Van Borsel J, De Cuypere G, Rubens R, Destaerke B. Voice problems in female-to-male transsexuals. Int J Lang Commun Disord 2000;35:427–42
- Glaser R, York AE, Dimitrakakis C. Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS). Maturitas 2011;68:355–61
- Glaser R, Dimitrakakis C. Testosterone and breast cancer prevention. Maturitas 2015;81:290–4
- Glaser RL, York AE, Dimitrakakis C. Efficacy of subcutaneous testosterone on menopausal symptoms in breast cancer survivors. J Clin Oncol 2014;32(Suppl 2):abstr 109
- Franco RA, Andrus JG. Common diagnoses and treatments in professional voice users. Otolaryngol Clin North Am 2007;40:1025–61
- Schwartz SR, Cohen SM, Dailey SH, et al. Clinical practice guideline: hoarseness (dysphonia). Otolaryngol-Head Neck Surg 2009;141:S1–31
- Sandage MJ, Plexico LW, Schiwitz A. Clinical Utility of CAPE-V Sentences for Determination of Speaking Fundamental Frequency. J Voice 2015;29:441–5
- Seaver EJ, Dalston RM, Leeper HA, Adams LE. A study of nasometric values for normal nasal resonance. J Speech Hear Res 1991;34:715–21
- Zraick RI, Kempster GB, Connor NP, et al. Establishing validity of the consensus auditory-perceptual evaluation of voice (CAPE-V). Am J Speech Lang Pathol 2011;20:14–22
- Baken RJ, Orlikoff RF. Clinical Measurement of Speech and Voice Singular. San Diego, CA: Thomson Learning, 2000:79
- Team RC. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing, 2013
- Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Software 2015;67:1–48
- Abaza MM, Levy S, Hawkshaw MJ, Sataloff RT. Effects of medications on the voice. Otolaryngol Clin North Am 2007;40:1081–90
- Tielen M. Fundamental frequency characteristics of middle aged men and women. Proc Inst Phonetic Sci Amsterdam 1989;13:49–58
- Traunmüller H, Eriksson A. Acoustic effects of variation in vocal effort by men, women, and children. J Acoust Soc Am 2000;107:3438–51
- Glaser R, Kalantaridou S, Dimitrakakis C. Testosterone implants in women: pharmacological dosing for a physiologic effect. Maturitas 2013;74:179–84
- Talaat M, Angelo A, Talaat AM, Elwany S, Kelada I, Thabet H. Histologic and histochemical study of effects of anabolic steroids on the female larynx. Ann Otol Rhinol Laryngol 1987;96:468–71
- Young MD, Blackmore WP. The use of danazol in the management of endometriosis. J Int Med Res 1977;5:86
- Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 2004;89:3313–18